Nathan G. Cortez, Nicolas Terry, et al.
August 16, 2017
August 10, 2017
July 6, 2017
A round-up of ACA-related developments, including hospital compliance with requirements for nonprofit status, litigation over protections against gender identity and pregnancy termination discrimination, a decision to continue CSR payments next month, developments on “bare” counties, and more.
On September 13 Health Affairs will sponsor a forum for policymakers to examine various frameworks for formally defining and measuring value and discuss the public policy issues and strategies attendant to their use.
August 18, 2017 | Elsewhere@ Health Affairs
While first appearing to be just another skirmish in the culture wars, ending the Teenage Pregnancy Prevention program fits within the Administration’s larger efforts to devalue science, data, and evidence.
Time has arrived for all managed care companies to claim a rightful seat at the table as experts in health services delivery by contributing in a scholarly domain.
One unorthodox but highly effective approach to addressing health and socioeconomic disparities in the United States would be to close the racial and ethnic wealth gap in our society by improving health.
Under a new administration, the FDA is experimenting with a new way to balance innovation and risk with emerging medical technologies.
August 16, 2017 | Health IT
On August 15, CBO and JCT released an analysis of the potential effects of terminating the ACA’s cost-sharing reduction (CSR) payments to insurers. The CBO affirms what earlier analyses have concluded: in the long run the primary loser if CSR payments are terminated would be the federal budget.
A CDC report found that the number of high school students who reported having artificially tanned has decreased by more than half since the enactment of the ACA, from 15.6 percent in 2009 to 7.3 percent in 2015.
If The Trump Administration Terminates Cost-Sharing Reduction Payments, States Can Use 1332 Waivers To Fund Their Own
Creating a State-administered CSR mechanism will undoubtedly require expenditure from the State. While some will argue that the limited resources in State budgets would render the idea all but theoretical, it would be beneficial to examine how States can use Section 1332 to fund CSRs.
It is true that evaluation results of payment reform models so far are not cause for celebration, but there are some positive cost and quality results and lessons are accumulating that can inform the next set of program parameters, incentive structures, and tools to help clinicians succeed.